Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
November 30, 2021
Patent Application Number
17245644
Date Filed
April 30, 2021
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
Described herein are methods of treating narcolepsy with cataplexy, comprising administering reboxetine (including esreboxetine) to a human being in need thereof. Reboxetine (including esreboxetine) may also be used in the manufacture of a medicament for the treatment of narcolepsy with cataplexy. Also disclosed herein are kits comprising a pharmaceutical composition comprising reboxetine (including esreboxetine) and instructions to use the pharmaceutical composition to treat narcolepsy with cataplexy in a human being.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
